[HTML][HTML] Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review
NN Shah, Z Khan, H Ahad, AY Elderdery… - Journal of infection and …, 2022 - Elsevier
Abstract As of 25th July, 2022, global Disease burden of 575,430,244 confirmed cases and
over 6,403,511 deaths have been attributed to coronavirus disease 2019 (COVID-19). Co …
over 6,403,511 deaths have been attributed to coronavirus disease 2019 (COVID-19). Co …
[PDF][PDF] Coronavirus disease-associated mucormycosis from a tertiary care hospital in India: a case series
Background: Coronavirus disease (COVID-19) remains a health concern with new
challenges emerging as the pandemic progresses. The recent rise of opportunistic infections …
challenges emerging as the pandemic progresses. The recent rise of opportunistic infections …
COVID-19 associated mucormycosis: a systematic review from diagnostic challenges to management
The coronavirus disease 2019 (COVID-19) outbreak has caused significant destruction,
claiming over three million lives worldwide. Post SARS-COV-2 invasion …
claiming over three million lives worldwide. Post SARS-COV-2 invasion …
[HTML][HTML] Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
yet to be controlled worldwide, especially in India. The second wave of coronavirus disease …
yet to be controlled worldwide, especially in India. The second wave of coronavirus disease …
Mucormycosis and COVID-19-associated mucormycosis: insights of a deadly but neglected mycosis
LC García-Carnero, HM Mora-Montes - Journal of Fungi, 2022 - mdpi.com
The ongoing COVID-19 pandemic has quickly become a health threat worldwide, with high
mortality and morbidity among patients with comorbidities. This viral infection promotes the …
mortality and morbidity among patients with comorbidities. This viral infection promotes the …
COVID-19-associated mucormycosis (CAM): an updated evidence mapping
Mucormycosis, a serious and rare fungal infection, has recently been reported in COVID-19
patients worldwide. This study aims to map all the emerging evidence on the COVID-19 …
patients worldwide. This study aims to map all the emerging evidence on the COVID-19 …
[HTML][HTML] Global prevalence of COVID-19-associated mucormycosis (CAM): living systematic review and meta-analysis
Mucormycosis, a secondary fungal infection, gained much attention in the ongoing COVID-
19 pandemic. This deadly infection has a high all-cause mortality rate and imposes a …
19 pandemic. This deadly infection has a high all-cause mortality rate and imposes a …
New insights on mucormycosis and its association with the COVID-19 pandemic
MG Alshahawey, GS El-Housseiny… - Future Science …, 2022 - Future Science
COVID-19 continues to cause significant fatality worldwide. Glucocorticoids prove to play
essential roles in COVID-19 management; however, the extensive use of steroids together …
essential roles in COVID-19 management; however, the extensive use of steroids together …
Current treatment options for COVID-19 associated mucormycosis: present status and future perspectives
Y Madhavan, KV Sai, DK Shanmugam… - Journal of Clinical …, 2022 - mdpi.com
Mucormycosis has become increasingly associated with COVID-19, leading to the use of the
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …
The past, present and future of COVID-19 associated mucormycosis: a rapid review
Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, which is known for the
multiple mutations and forms that have rapidly spread across the world. With the imminent …
multiple mutations and forms that have rapidly spread across the world. With the imminent …